Competitive NMDA receptor antagonists and agonist: Effects on spontaneous alternation in mice exposed to cerebral oligemia

Polish Journal of Pharmacology

Volumn 56, Issue 1, 2004, Pages 59-66

  Jóźwiak, Lucyna ^a   Łukawski, Krzysztof ^a   Czuczwar, Stanisław J ^b,c   Sieklucka Dziuba, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b Medical University   (Poland)

^c INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Cerebral oligemic hypoxia; CGP 37849; CGP 39551; NMDA; Spontaneous alternation

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; PENTOBARBITAL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CLAMP; ARTICLE; BRAIN HYPOXIA; CAROTID ARTERY; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG RESPONSE; DRUG SENSITIVITY; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; STATISTICAL ANALYSIS; TASK PERFORMANCE;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; BEHAVIOR, ANIMAL; CAROTID ARTERY INJURIES; CEREBROVASCULAR CIRCULATION; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION, PRECLINICAL; HYPOVOLEMIA; HYPOXIA, BRAIN; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; N-METHYLASPARTATE; ORIENTATION; PLACEBOS; POLAND; RECEPTORS, N-METHYL-D-ASPARTATE; TIME FACTORS;

EID: 1942517286     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Albers GW, Goldberg MP, Choi DW: N-Methyl-D-aspartate antagonist: ready for clinical trial in brain ischemia? Ann Neurol, 1989, 25, 398-403.
2. Anisman H: Dissociation of disinhibitory effects of scopolamine: strain and task factors. Pharmacol Biochem Behav, 1975, 3, 613-618.
3. Benveniste H, Drejer J, Schousboe A, Diemer NH: Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem, 1984, 43, 1369-1374.
4. Bischoff C, Tiedtke PI: Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks. Eur J Pharmacol, 1992, 213, 269-273.
5. Borowicz KK, Duda AM, Kleinrok Z, Czuczwar SJ: Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats. Pol J Pharmacol, 2001, 53, 101-108.
6. Bortolotto ZA, Heim C, Sieklucka M, Block F, Sontag KH, Cavalheiro EA: Effects of bilateral clamping of carotid arteries on hippocampal kindling in rats. Physiol Behav, 1991, 49, 667-671.
7. Chadwik DW, Betts TA, Boddie HG, Crawford PM, Lindstrom P, Newman PK, Soryal I, Wroe S, Holdich TA: Remacemide hydrochloride as an add-on therapy in epilepsy: a randomized, placebo-controlled trial of three dose levels (300, 600 and 1200 mg/day) in a QID regimen. Seizure, 2002, 11, 114-123.
8. Clineschmidt BV: Effect of the benzodiazepine receptor antagonist Ro 15-1788 on the anticonvulsant and anticonflict actions of MK-801. Eur J Pharmacol, 1982, 84, 119-121.
9. Cole SO: Effects of benzodiazepines on acquisition and performance: a critical assessment. Neurosci Biobehav Rev, 1986, 10, 265-272.
10. Curran HV. Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol, 1986, 23, 179-213.
11. Czuczwar SJ, Kleinrok Z, Turski WA: Interaction of calcium channel blockers and excitatory amino acid antagonists with conventional antiepileptic drugs. CNS Drug Rev, 1996, 2, 452-467.
12. Czuczwar SJ, Patsalos PN: The new generation of GABA enhancers. Potential in the treatment of epilepsy. CNS Drugs, 2001, 15, 339-350.
13. Danysz W, Wróblewski JT, Costa E: Learning impairment in rats by N-methyl-D-aspartate receptor antagonists. Neuropharmacology, 1988, 27, 653-656.
14. Deacon RMJ, Rawlins JNP: Effects of the competitive NMDA receptor antagonist CGP 37849 on performance of reference and working memory tasks by rats. Eur J Pharmacol, 1995, 280, 239-242.
15. A receptor complex and potentiates flurazepam's antiseizure efficacy. Pharmacol Biochem Behav, 1995, 51, 909-915.
16. Flood JF, Baker ML, Davis JL: Modulation of memory processing by glutamic acid receptor agonists and antagonists. Brain Res, 1990, 521, 197-202.
17. Franklin KBJ, Paxinos G: The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, London, 1997.
18. Ginsberg MD, Takagi K, Globus MY-T: Release of neurotransmitters in cerebral ischemia: relevance to neuronal injury. In: Pharmacology of Cerebral Ischemia. Ed. Krieglstein J, Oberpichler-Schwenk H, Wiss Verl-Ges, Stuttgart, 1992, 177-190.
19. Globus MY-T, Busto R, Martinez E, Valdés I, Dietrich DW, Ginsberg MD: Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat. J Neurochem, 1991, 57, 470-478.
20. Graham SH, Shiraishi K, Panter SS, Simon RP, Faden AI: Changes in extracellular amino acid neurotransmitters; produced by focal cerebral ischemia. Neurosci Lett, 1990, 110, 124-130.
21. Gutnikov SA, Rawlins JNP: Systemic NMDA antagonist CGP-37849 produces non-specific impairment in a working memory task: the effect does not resemble those of AP5 and of lesions of the hippocampus or fornix. Neuropsychologia, 1996, 34, 311-314.
22. Heim C, Sieklucka M, Block F, Schmidt-Kastner R, Jaspers R, Sontag K-H: Transient occlusion of carotid arteries leads to disturbed spatial learning and memory in the rat. In: Pharmacology of Cerebral Ischemia. Ed. Krieglstein J, Oberpichler H, Wiss Verl-Ges, Stuttgart, 1990, 53-61.
23. Heim C, Zhang J, Lan J, Sieklucka M, Kurz T, Riederer P, Gerlach M, Sontag K-H: Cerebral oligaemia episode triggers free radical formation and late cognitive deficiencies. Eur J Neurosci, 2000, 12, 715-725.
24. Jaspers RMA, Block F, Heim C, Sontag K-H: Spatial learning is affected by transient occlusion of common carotid arteries (2VO): comparison of behavioral and histopathological changes after " 2VO" and fourvessel-occlusion in rats. Neurosci Lett, 1990, 117, 149-153.
25. Jóźwiak L, Sieklucka-Dziuba M, Kleinrok Z: Behavioral studies of the effects of moderate oligemic hypoxia caused by bilateral clamping of carotid arteries in mice. Impairment of spatial working memory. Pol J Pharmacol, 1998, 50, 279-289.
26. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res, 1982, 239, 57-69.
27. Kretschmer BD, Zadow B, Volz TL, Schmidt WJ: The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior. J Neural Transm Gen Sect, 1992, 87, 23-35.
28. Kwan P, Brodie MJ: Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology, 2003, 60, 2-12.
29. Läer S, Block F, Hüther G, Heim C, Sontag K-H: Effect of transient reduction of cerebral blood flow in normotensive rats on striatal dopamine-release. J Neural Transin Gen Sect, 1993, 92, 203-211.
30. Löscher W, Hönack D: Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J Pharmacol Exp Ther, 1991, 256, 432-440.
31. Mason KI, Mallet PE, Jhamandas K, Boegman RJ, Beninger RJ: Nucleus basalis injections of N-methyl-Daspartate enhance memory of rats in the double Y-maze. Brain Res Bull, 1999, 48, 65-71.
32. Maurice T, Su T-P, Parish DW, Nabeshima T, Privat A: PRE-084, a δ selective PCP derivative, attenuates MK-801-induced impairment of learning in mice. Pharmacol Biochem Behav, 1994, 49, 859-869.
33. Melzacka M, Weiner N, Heim C, Schmidt-Kastner R, Sieklucka M, Sontag, K-H, Wesemann W: Effect of transient reduction of cerebral blood flow on membrane anisotropy and lipid peroxidation in different rat brain areas. Neurochem Int, 1994, 25, 161-168.
34. Morris RGM, Anderson E, Lynch GS, Baudry M: Selective impairment of Naming and blockade of longterm potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature, 1986, 319, 774-776.
35. Morris RGM, Garrund P, Rawlins JNP, O'Keefe J: Place navigation impaired in rats with hippocampal lesions. Nature, 1982, 297, 681-683.
36. Nadlewska, A, Car H, Wiśniewska RJ, Wiśniewski K: Behavioral effects of the selective blockade of metabotropic glutamate receptor subtype 5 in experimental hypoxia. Pol J Pharmacol, 2002, 54, 95-102.
37. Nadlewska A, Car H, Wiśniewska RJ, Wiśniewski K: Influence of AIDA on certain behaviors in rats subjected to experimental hypoxia. Pol J Pharmacol, 2003, 55, 171-180.
38. Ohno M, Yamamoto T, Watanabe S: Effects of intrahippocampal injections of N-methyl-D-aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three-panel runway task. J Pharmacol Exp Ther, 1992, 263, 943-950.
39. Oksztel R, Car H, Wiśniewski K: Muscimol changes hypoxia-induced impairment of behavior. Pol J Pharmacol, 2002, 54, 423-431.
40. Olney JW, Price MT, Labruyere J, Salles KS, Frierdich G, Mueller M, Silverman E: Antiparkinsonian agents are phencyclidine agonists and N-methyl-D-aspartate antagonists. Eur J Pharmacol, 1987, 142, 319-320.
41. Parada J, Czuczwar SJ, Turski WA: NBQX does not affect learning and memory tasks in mice: a comparison with D-CPPene and ifenprodil. Brain Res Cogn Brain Res, 1992, 1, 67-71.
42. Parada-Turska J, Turski WA: Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology, 1990, 29, 1111-1116.
43. Park CK, Nehls DG, Graham DI, Teasolate GM, Mc Culloch J: The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann Neurol, 1988, 24, 543-551.
44. Pulsinelli WA, Brierley JB, Plum F: Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol, 1982, 11, 491-498.
45. Rejdak Y, Rejdak R, Kleinrok Z, Sieklucka-Dziuba M: The influence of MK-801 on bicuculline-evoked seizures in adult mice exposed to transient episode of brain ischemia. J Neural Transm, 2000, 107, 947-957,
46. Rejdak R, Rejdak Y, Sieklucka-Dziuba M, Stelmasiak Z, Grieb P: Brain tolerance and preconditioning. Pol J Pharmacol, 2001, 53, 73-79.
47. Rejdak K, Rejdak R, Stelmasiak Z, Czuczwar SJ, Kleinrok Z, Sieklucka-Dziuba M: The effect of CGP-40116 on pilocarpine evoked seizures in mice exposed to transient episode of brain ischemia. Epilepsy Res, 2000, 41, 213-222.
48. Sarter M, Bodewitz G, Stephens DN: Attenuation of scopolamine-induced impairment of spontaneous alternation behavior by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology, 1988, 94, 491-495.
49. Sarti C, Pantoni L, Bartolini L, Inzitari D: Persistent impairment of gait performances and working memory after bilateral common carotid artery occlusion in the adult Wistar rat. Behav Brain Res, 2002, 136, 13-20.
50. Schmidt-Kastner R, Freund TF: Selective vulnerability of the hippocampus in brain ischemia. Neuroscience, 1991, 40, 599-636.
51. Schmutz M, Portet Ch, Jeker A, Klebs K, Vassout A, Allgeier H, Heckendorn R, Fagg GE, Olpe H-R, Van Riezen H: The competitive NMDA receptor antagonists CGP37849 and CGP39551 are potent, orally-active anticonvulsants in rodents. Naunyn Schmiedebergs Arch Pharmacol, 1990, 342, 61-66.
52. Sieklucka M, Heim C, Block F, Sontag K-H: Transient reduction of cerebral blood flow leads to longlasting increase in GABA content in vulnerable structures and decreased susceptibility to bicuculline-induced seizures. J Neural Transm Gen Sect, 1992, 88, 87-94.
53. Sieklucka M, Löscher W, Heim C, Sontag K-H: Influence of short-lasting bilateral clamping of carotid arteries (BCCA) on GABA turnover in rat brain structures. Neurochem Res, 1994, 19, 367-372.
54. Smith MZ, Auer RN, Siesjo BK: The density and distribution of ischemic brain injury in rats following 2-10 min of forebrain ischemia. Acta Neuropathol, 1984, 64, 319-332.
55. Sontag K-H, Heim C, Block F, Sieklucka M, Schmidt-Kastner R, Melzacka M, Osborne N et al.: Cerebral oligemic hypoxia and forebrain ischemia - common and different long-lasting consequences. In: Pharmacology of Cerebral Ischemia. Ed, Krieglstein J, Oberpichler-Schwenk H, Wiss Verl-Ges, Stuttgart, 1992, 471-479.
56. Urbańska E, Dziki M, Czuczwar SJ, Kleinrok Z, Turski WA: Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures. Neuropharmacology, 1992, 31, 1021-1026.
57. Woźniak DF, Brosnan-Watters G, Nardi A, Mc Ewen M, Corso TD, Olney JW, Fix AS: MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning. Brain Res, 1996, 707, 165-179.
58. Ylinen A, Pitkänen M, Sirviö J, Hartikainen T, Sivenius J, Koivisto E, Riekkinen PJ: The effects of NMDA receptor antagonists at anticonvulsive doses on the performance of rats in the water maze task. Eur J Pharmacol, 1995, 274, 159-165.
59. Zajaczkowski W, Frankiewicz T, Parsons CG, Danysz W: Uncompetitive NMDA receptor antagonists attenuate NMDA-induced impairment of passive avoidance learning and LTP: Neuropharmacology, 1997, 36, 961-971.